Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutamate transporters and presynaptic glutamate release machinery represent a complex system of proteins that regulate the life cycle of glutamate, the brain's primary excitatory neurotransmitter. This system includes vesicular glutamate transporters (VGLUTs) for vesicle loading, the SNARE complex and associated proteins for calcium-dependent exocytosis, and excitatory amino acid transporters (EAATs) for rapid clearance of glutamate from the synapse (PMID: 23515018, 28130354). Proper functioning of this machinery is essential for maintaining synaptic homeostasis and preventing excitotoxicity, a process where excessive glutamate overstimulates receptors and leads to neuronal death (PMID: 15637273). Dysregulation is implicated in a wide range of pathologies, including amyotrophic lateral sclerosis (ALS), epilepsy, and stroke. Pharmacological interventions, such as riluzole, target these components to modulate release or enhance uptake, thereby providing neuroprotection and stabilizing neuronal excitability (PubChem CID 5070). Additionally, drugs like levetiracetam interact with synaptic vesicle proteins to modulate the probability of neurotransmitter release in epilepsy (PMID: 15146178). Research into upregulating EAAT2 expression remains a significant area of interest for treating neurodegenerative diseases. Overall, this machinery is a critical focal point for drug development aimed at restoring excitatory balance in the central nervous system.
Modulation of glutamate release through inhibition of presynaptic voltage-gated sodium or calcium channels, stabilization of the SNARE complex, or upregulation of excitatory amino acid transporters (EAATs) to enhance glutamate clearance from the synaptic cleft.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate transporters and presynaptic glutamate release machinery.